Curemark announced it raised $1.3 Million in an initial filing from an offering of $15 Million
03/27/23, 4:21 PM
Location
Money raised
$1.3 million
Industry
biopharma
therapeutics
pharmaceutical
health care
biotechnology
Round Type
seed
Company Info
Location
800 westchester avenue
village of rye brook, new york, united states
Additional Info
Curemark is a private, clinical-stage biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and neurodegenerative disorders. The company's pipeline includes preclinical and clinical-stage programs for the treatment of autism, schizophrenia, Parkinson's disease, ADHD and addiction.